Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
4-hydroxyphenylacetate 1-monooxygenase (EC 1.14.13.18) is a microbial enzyme that catalyzes the oxidative decarboxylation of 4-hydroxyphenylacetate to produce hydroquinone and carbon dioxide. This reaction requires NAD(P)H and molecular oxygen as co-substrates. The enzyme is primarily found in bacteria such as Pseudomonas acidovorans and certain yeast species like Candida parapsilosis, where it serves as a key step in the degradation of aromatic compounds derived from the amino acid tyrosine. By converting 4-hydroxyphenylacetate into hydroquinone, which can then be further metabolized into central metabolic intermediates, the enzyme allows these microorganisms to utilize phenolic compounds as a carbon and energy source. Currently, 4-hydroxyphenylacetate 1-monooxygenase is not recognized as a therapeutic target for human diseases, nor are there any clinical drugs known to interact with it. Its primary significance lies in the fields of microbial physiology, environmental biochemistry, and potential industrial applications for the biocatalytic production of hydroquinone.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 4-hydroxyphenylacetate 1-monooxygenase.